date:Jul 29, 2022
Nestls Nutrition Health Science marked a CHF 7.7 billion (US$8 billion) sales growth in the first half of the year, the companys latest financial results have revealed. The Infant Nutrition segment returned to positive growth in China, reaching an unspecified high single-digit rate.
Nestls CEO Mark Schneider explains the company was not immune to inflationary pressures and supply chain challenges, as vitamins, minerals and supplements reported low single-digit growth, following strong growth i